{"name": "Unigene Laboratories",
 "permalink": "unigene-laboratories",
 "crunchbase_url": "http://www.crunchbase.com/company/unigene-laboratories",
 "homepage_url": "http://www.unigene.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1980,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "jthomas@unigene.com",
 "phone_number": "(973) 265-1100",
 "description": "",
 "created_at": "Thu Mar 18 11:08:50 UTC 2010",
 "updated_at": "Wed May 29 12:18:28 UTC 2013",
 "overview": "\u003Cp\u003EFounded in 1980, Unigene is a publicly traded biopharmaceutical company with corporate offices, an R\u0026amp;D facility and a state-of-the-art recombinant manufacturing facility in New Jersey.  There broad experience in molecular biology, protein chemistry, immunology and formulation development combined with there entrepreneurial spirit and innovation have led to the development of proprietary technologies, protected by a strong patent portfolio, enabling the commercialization of peptide drugs.  \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       75],
      "assets/images/resized/0008/0802/80802v1-max-150x150.png"],
     [[200,
       100],
      "assets/images/resized/0008/0802/80802v1-max-250x250.png"],
     [[200,
       100],
      "assets/images/resized/0008/0802/80802v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Ashleigh",
      "last_name": "Palmer",
      "permalink": "ashleigh-palmer",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Technology Transfer and Contract Manufacturing Services",
    "person":
     {"first_name": "Paul",
      "last_name": "Shields, Ph.D.",
      "permalink": "paul-shields-ph-d",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Global Regulatory Affairs",
    "person":
     {"first_name": "Roxanne",
      "last_name": "Tavakkol",
      "permalink": "roxanne-tavakkol",
      "image": null}},
   {"is_past": false,
    "title": "Vice President of Finance",
    "person":
     {"first_name": "William",
      "last_name": "Steinhauer",
      "permalink": "william-steinhauer",
      "image": null}},
   {"is_past": false,
    "title": "",
    "person":
     {"first_name": "Warren",
      "last_name": "Levy",
      "permalink": "warren-levy",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Biological Research and Development",
    "person":
     {"first_name": "Nozer",
      "last_name": "Mehta, Ph.D.",
      "permalink": "nozer-mehta-ph-d",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Corporate Development and General Counsell Counsel",
    "person":
     {"first_name": "Gregory",
      "last_name": "Mayes",
      "permalink": "gregory-mayes",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Investor Relations and Business Administration",
    "person":
     {"first_name": "Jenene",
      "last_name": "Thomas",
      "permalink": "jenene-thomas",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$14.4M",
 "funding_rounds":
  [{"round_code": "debt_round",
    "source_url": "http://www.fiercebiotech.com/story/unigene-labs-raises-13-6m-debt-restructuring/2010-03-17?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Unigene Labs raises $13.6M in debt restructuring",
    "raised_amount": 13600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 17,
    "investments":
     []},
   {"round_code": "debt_round",
    "source_url": "http://www.sec.gov/Archives/edgar/data/352747/000157493913000001/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 750000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 22,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "81 Fulton St",
    "address2": "",
    "zip_code": "07005 ",
    "city": "Boonton",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Unigene\u00e2\u20ac\u2122s oral peptide drug delivery technology validated with positive top-line Phase 3 results from Tarsa\u00e2\u20ac\u2122s ORACAL trial of Oral Calcitonin.",
    "stoned_year": 2011,
    "stoned_month": 3,
    "stoned_day": 14,
    "source_url": "http://www.unigene.com/content/investors-and-media/press-releases-detail.php?reqid=1542457",
    "source_text": null,
    "source_description": "Unigene Laboratories, Inc",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Unigene Laboratories",
      "permalink": "unigene-laboratories"}},
   {"description": "Unigene completes patient enrollment of oral PTH Phase 2 study for the treatment of osteoporosis in postmenopausal women.",
    "stoned_year": 2011,
    "stoned_month": 4,
    "stoned_day": 17,
    "source_url": "http://www.unigene.com/content/investors-and-media/press-releases-detail.php?reqid=1555297",
    "source_text": null,
    "source_description": "Unigene Laboratories, Inc",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Unigene Laboratories",
      "permalink": "unigene-laboratories"}},
   {"description": "Unigene announces manufacturing and clinical supply agreement with Cara Therapeutics for Phase 1 study of Novel Kappa Receptor Agonist.",
    "stoned_year": 2011,
    "stoned_month": 5,
    "stoned_day": 19,
    "source_url": "http://www.unigene.com/content/investors-and-media/press-releases-detail.php?reqid=1565491",
    "source_text": null,
    "source_description": "Unigene Laboratories, Inc",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Unigene Laboratories",
      "permalink": "unigene-laboratories"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        44],
       "assets/images/resized/0013/8496/138496v2-max-150x150.jpg"],
      [[250,
        74],
       "assets/images/resized/0013/8496/138496v2-max-250x250.jpg"],
      [[450,
        134],
       "assets/images/resized/0013/8496/138496v2-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  [{"external_url": "http://www.unigene.com/index.php",
    "title": "Unigene Laboratories, Inc."}]}